Results
|
|
1561.
|
|
|
|
1562.
|
Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. [electronic resource] by
- Formisano, Luigi
- Nappi, Lucia
- Rosa, Roberta
- Marciano, Roberta
- D'Amato, Claudia
- D'Amato, Valentina
- Damiano, Vincenzo
- Raimondo, Lucia
- Iommelli, Francesca
- Scorziello, Antonella
- Troncone, Giancarlo
- Veneziani, Bianca
- Parsons, Sarah J
- De Placido, Sabino
- Bianco, Roberto
Producer: 20150416
In:
Breast cancer research : BCR vol. 16
Availability: No items available.
|
|
|
1563.
|
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial. [electronic resource] by
- Lopez-Chavez, Ariel
- Thomas, Anish
- Rajan, Arun
- Raffeld, Mark
- Morrow, Betsy
- Kelly, Ronan
- Carter, Corey Allan
- Guha, Udayan
- Killian, Keith
- Lau, Christopher C
- Abdullaev, Zied
- Xi, Liqiang
- Pack, Svetlana
- Meltzer, Paul S
- Corless, Christopher L
- Sandler, Alan
- Beadling, Carol
- Warrick, Andrea
- Liewehr, David J
- Steinberg, Seth M
- Berman, Arlene
- Doyle, Austin
- Szabo, Eva
- Wang, Yisong
- Giaccone, Giuseppe
Producer: 20150528
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33
Availability: No items available.
|
|
|
1564.
|
PUMA and BIM are required for oncogene inactivation-induced apoptosis. [electronic resource] by
- Bean, Gregory R
- Ganesan, Yogesh Tengarai
- Dong, Yiyu
- Takeda, Shugaku
- Liu, Han
- Chan, Po M
- Huang, Yafen
- Chodosh, Lewis A
- Zambetti, Gerard P
- Hsieh, James J-D
- Cheng, Emily H-Y
Producer: 20130909
In:
Science signaling vol. 6
Availability: No items available.
|
|
|
1565.
|
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. [electronic resource] by
- Venturutti, L
- Cordo Russo, R I
- Rivas, M A
- Mercogliano, M F
- Izzo, F
- Oakley, R H
- Pereyra, M G
- De Martino, M
- Proietti, C J
- Yankilevich, P
- Roa, J C
- Guzmán, P
- Cortese, E
- Allemand, D H
- Huang, T H
- Charreau, E H
- Cidlowski, J A
- Schillaci, R
- Elizalde, P V
Producer: 20170906
In:
Oncogene vol. 35
Availability: No items available.
|
|
|
1566.
|
|
|
|
1567.
|
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer. [electronic resource] by
- Johnston, Stephen
- Pippen, John
- Pivot, Xavier
- Lichinitser, Mikhail
- Sadeghi, Saeed
- Dieras, Veronique
- Gomez, Henry Leonidas
- Romieu, Gilles
- Manikhas, Alexey
- Kennedy, M John
- Press, Michael F
- Maltzman, Julie
- Florance, Allison
- O'Rourke, Lisa
- Oliva, Cristina
- Stein, Steven
- Pegram, Mark
Producer: 20100105
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27
Availability: No items available.
|
|
|
1568.
|
An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models. [electronic resource] by
- Xia, Wenle
- Petricoin, Emanual F
- Zhao, Sumin
- Liu, Leihua
- Osada, Takuya
- Cheng, Qing
- Wulfkuhle, Julia D
- Gwin, William R
- Yang, Xiaoyi
- Gallagher, Rosa I
- Bacus, Sarah
- Lyerly, H Kim
- Spector, Neil L
Producer: 20140911
In:
Breast cancer research : BCR vol. 15
Availability: No items available.
|
|
|
1569.
|
|
|
|
1570.
|
|
|
|
1571.
|
Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy. [electronic resource] by
- García-García, Celina
- Ibrahim, Yasir H
- Serra, Violeta
- Calvo, Maria Teresa
- Guzmán, Marta
- Grueso, Judit
- Aura, Claudia
- Pérez, José
- Jessen, Katti
- Liu, Yi
- Rommel, Christian
- Tabernero, Josep
- Baselga, José
- Scaltriti, Maurizio
Producer: 20120830
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
|
1572.
|
|
|
|
1573.
|
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. [electronic resource] by
- Dai, Chun-ling
- Tiwari, Amit K
- Wu, Chung-Pu
- Su, Xiao-Dong
- Wang, Si-Rong
- Liu, Dong-geng
- Ashby, Charles R
- Huang, Yan
- Robey, Robert W
- Liang, Yong-ju
- Chen, Li-ming
- Shi, Cheng-Jun
- Ambudkar, Suresh V
- Chen, Zhe-Sheng
- Fu, Li-wu
Producer: 20081126
In:
Cancer research vol. 68
Availability: No items available.
|
|
|
1574.
|
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies. [electronic resource] by
- Deeken, John F
- Wang, Hongkun
- Subramaniam, Deepa
- He, Aiwu Ruth
- Hwang, Jimmy
- Marshall, John L
- Urso, Christina E
- Wang, Yiru
- Ramos, Corinne
- Steadman, Kenneth
- Pishvaian, Michael J
Producer: 20150713
In:
Cancer vol. 121
Availability: No items available.
|
|
|
1575.
|
|
|
|
1576.
|
Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer. [electronic resource] by
- Nam, Hyun-Jin
- Im, Seock-Ah
- Oh, Do-Youn
- Elvin, Paul
- Kim, Hwang-Phill
- Yoon, Young-Kwang
- Min, Ahrum
- Song, Sang-Hyun
- Han, Sae-Won
- Kim, Tae-You
- Bang, Yung-Jue
Producer: 20130627
In:
Molecular cancer therapeutics vol. 12
Availability: No items available.
|
|
|
1577.
|
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. [electronic resource] by
- Liu, Shuzhen
- Chen, Bingshu
- Burugu, Samantha
- Leung, Samuel
- Gao, Dongxia
- Virk, Shakeel
- Kos, Zuzana
- Parulekar, Wendy R
- Shepherd, Lois
- Gelmon, Karen A
- Nielsen, Torsten O
Producer: 20171120
In:
JAMA oncology vol. 3
Availability: No items available.
|
|
|
1578.
|
|
|
|
1579.
|
|
|
|
1580.
|
|